Sorry, you need to enable JavaScript to visit this website.

    Pfizer Recognized as Leader in Improving Climate Change for Second Consecutive Year

    (BUSINESS WIRE)--Pfizer Inc announced today that for the second consecutive year it was recognized for its approach to improving the environment by being named to the Climate Disclosure Leadership Index (CDLI) by the Carbon Disclosure Project (CDP). The CDP is a not-for-profit coalition of 385 global investors with $57 trillion in assets under management.

    Pfizer was one of 383 Fortune 500 companies -- and one of nine in the chemical and pharmaceutical sector -- named in the CDLI, a prestigious honor roll for global corporations addressing the challenges of climate change.

    Pfizer is a leader among its peers through its voluntary reductions in greenhouse gas emissions and commitment to renewable energy, CDP Chief Executive Paul Dickinson said. Good corporate governance in respect of climate change disclosure will inevitably reap its rewards. As carbon regulation increases, those companies that have implemented climate change related strategies are clearly going to be in a far better position to meet the challenge of higher carbon prices than companies that have procrastinated. Good disclosure practices are synonymous with good management.

    Pfizers purpose is working together for a healthier worldand while its primary commitment is to the discovery and provision of innovative medicines, it recognizes that increasingly this goal extends beyond products alone. Improving health occurs not only through this commitment but also by advancing programs that deliver sustainable solutions to the health care challenges facing the changing world.

    Our Energy and Climate Change program addresses sustainability through our conservation guidelines, energy efficient projects, emission reduction goals, and green buildings. Energy teams and colleagues at Pfizer facilities around the world completed more than 430 conservation-related projects during 2007, an increase of 40 projects over the previous year, and a commendable achievement, demonstrating our commitment to program advancement, said Steve Brooks, vice president of Global Environment Health & Safety for Pfizer.

    Pfizer has had a company standard requiring the conservation of energy and reduction of greenhouse gases since 1996. In 2002, Pfizer became a charter member of the Climate Leaders Program, a partnership between the U.S. Environmental Protection Agency (EPA) and industry that aims to develop long-term, comprehensive climate change strategies and sets greenhouse gas emissions reduction goals. As a Climate Leader, Pfizer established a company-wide intensity goal of reducing CO2 emissions by 35 percent per million dollars of revenue and most recently, a second generation CO2 goal that targets a 20% reduction on an absolute basis by 2012. The company is also evaluating and implementing a number of projects that generate electricity from clean energy sources.

    Pfizer Inc: Working together for a healthier world

    Founded in 1849, Pfizer is the worlds largest research-based pharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and provide better quality health care and health system support. At Pfizer, 85,000 colleagues work every day to help people stay happier and healthier longer and to reduce the human and economic burden of disease worldwide.

    About CDP

    The Carbon Disclosure Project, founded in 2000, represents some 385 global institutional investors with more than $57 trillion in assets under management. As an independent not-for-profit organization, CDP collects key climate change data from more than 1550 major corporations around the globe and has assembled the largest corporate greenhouse gas emissions database in the world. CDP also works with multinational organizations to facilitate the collection of climate change relevant data from their supply chains.

    CDP makes its requests for information and the corporate responses to such requests publicly available for the benefit of all interested parties including policymakers and their advisors. For more information regarding CDP please go to

    The Carbon Disclosure Project, a company limited by guarantee and registered in England (no. 05013650), is a Registered Charity (no. 1122330). CDP also enjoys 501(c)3 charitable status in the US as a special project of Rockefeller Philanthropy Advisors.

    Pfizer Inc
    Chris Loder, 212-733-7897

    Sign up for the latest Pfizer Wire news alerts

    Receive real-time updates on Pfizer’s news delivered directly to your inbox.

    Our Pipeline: Potential Breakthroughs in the Making

    We're elevating our breakthroughs in a bold new way. Check out our new visualized product pipeline.

    Corporate Fact Sheet

    For more than 170 years, Pfizer has worked to make a difference for all who rely on us.

    Media Asset Library

    Click here to view our media asset library.

    Pfizer Logo

    Our logo is shorthand for everything Pfizer represents: an image that is instantly identifiable to our colleagues, patients, the external scientific community, and the public.

    Executive Leadership

    Meet the executive leadership team, our senior-most leadership and decision-making management body who focus on major financial, strategic, and operational decisions for the entire company.

    Stay up to date on the latest news and alerts through the Pfizer Wire

    Sign up to receive real-time updates on Pfizer’s news from the Pfizer Media Relations team delivered directly to your inbox. 


    Sign Up Now